CNTX Context Therapeutics Inc
Company Analysis
Latest News
🔴 Context Therapeutics falls 6.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Context Therapeutics is trading 8% up in pre-market amid broader market gains
Context Therapeutics is trading 8% up at $0.46 in pre-market, with the move appearing aligned with broader risk-on sentiment rather than a confirmed...
🔴 Context Therapeutics is trading 5.8% down in pre-market with no confirmed company-specific catalyst
Context Therapeutics is trading at $0.41, down -5.83% in pre-market on August 26, 2026, with no confirmed company-specific catalyst identified. - The latest...
🔴 Context Therapeutics is trading 11.15% down today with specific cause unclear
Context Therapeutics is trading at $0.41, down 11.15%, after opening-session weakness on August 25, 2026, with no specific cause confirmed. - No new...
🔴 Context Therapeutics is trading 5.5% down today with no clear catalyst
Context Therapeutics is trading 5.5% down at $0.44 after opening-session weakness, with no clear catalyst confirmed. - The stock fell 6.94% to $0.47 on August...
🟢 Context Therapeutics is trading 5.46% up in pre-market with no confirmed company-specific catalyst identified
Context Therapeutics is trading at $0.49, up 5.46%, after no confirmed company-specific announcement or overnight catalyst was identified for the pre-market...
🔴 Context Therapeutics is trading 5% down today; no confirmed company-specific catalyst
On August 24, 2026, Context Therapeutics is trading at $0.47, down -5.08% (5% down), with no confirmed company-specific catalyst identified. - The latest...
🔴 Context Therapeutics is trading 6% down in pre-market with no confirmed company-specific catalyst
Context Therapeutics is trading 6.02% down at $0.47 after no confirmed company-specific catalyst was identified for August 24, 2026. - The latest...
🟢 Context Therapeutics is trading 8% up in pre-market with no confirmed catalyst
Context Therapeutics is trading at $0.54, up 7.98%, after no confirmed company-specific catalyst was identified for August 24, 2026. - The latest...
🔴 Context Therapeutics is trading 6.97% down in pre-market with no confirmed company-specific catalyst identified
Context Therapeutics is trading 6.97% down at $0.48, with no company-specific announcement or confirmed overnight catalyst identified for August 21, 2026. -...
🟢 Context Therapeutics is trading 5% up today amid trading volatility
Context Therapeutics is trading 5.13% up at $0.51, with the gain appearing to reflect trading volatility rather than a confirmed fundamental catalyst. - No...
🔴 Context Therapeutics is trading 6.73% down today as the specific cause remains unclear
Context Therapeutics is trading 6.73% down now at $0.46, with the specific cause unclear and no confirmed company-specific announcement dated August 19,...
🔴 Context Therapeutics is trading 5.26% down today as Nasdaq Composite falls 1.32%
Context Therapeutics is trading 5.26% down at $0.50 amid broader market weakness, with the Nasdaq Composite down 1.32% and the S&P 500 down 0.58%. - No fresh...
🟢 Context Therapeutics is trading 5% up today — no confirmed catalyst identified
Context Therapeutics is trading 5.17% up now at $0.53 on August 14, 2026, with no new company-specific announcement, filing, earnings release, or analyst...
🟢 Context Therapeutics is trading 5.1% up today on softer PPI and lower Fed hike expectations
Context Therapeutics is trading at $0.49, up +5.11% on August 13, 2026, as softer-than-expected July PPI and slightly higher jobless claims reduced...
🔴 Context Therapeutics is trading 8% down today after Q2 EPS miss and CT-95 discontinuation
Context Therapeutics is trading 8% down now at $0.45 after investors continued reassessing its August 5 second-quarter report. - The company posted a $14.6...
Context Therapeutics Drops 18.5% After Hours: Is the CTIM-76 Hype Trade Running Out of Steam?
Shares of Context Therapeutics slid to $0.56 in after-hours trading Thursday, erasing a chunk of the gains from a rally that had lifted the micro-cap biotech...
🔴 Context Therapeutics is trading 25% down today after $14.6 million Q2 net loss
Context Therapeutics is trading 25% down at $0.52 after reporting a $14.6 million second-quarter net loss and missing consensus EPS estimates by $0.05. -...
🔴 Context Therapeutics Plunges 22.1% in Premarket on Wider Q2 Loss, EPS Miss, and Pipeline Prioritization
Context Therapeutics is trading 22.1% down at $0.54 in pre-market, extending a sharp after-hours selloff after reporting its Q2 2026 financial results. The...
🔴 Context Therapeutics is trading 24.2% down today ahead of Q2 earnings release
Context Therapeutics is trading 24.2% down at $0.53 in after-hours trading as investors position ahead of the company’s upcoming quarterly financial...